Suchergebnisse - sars-cov-2

PubPharm (11.631)

1

Immunogenicity and safety of SARS-CoV-2 recombinant protein subunit vaccine (IndoVac) adjuvanted with alum and CpG 1018 in Indonesian adults : A phase 3, randomized, active-controlled, multicenter trial

enthalten in: Vaccine | 2024

von Nurdin, A. | Movieta Nency, Y. | Maddeppungeng, M. | +24

2

Detection of SARS-CoV-2-specific mucosal antibodies in saliva following concomitant COVID-19 and influenza vaccination in the ComFluCOV trial

enthalten in: Vaccine | 2024

von Baum, H. | Thirard, R. | Halliday, A. | +13

3

The humoral immune response to the BNT 162B2 vaccine in pediatrics on renal replacement therapy

enthalten in: Pediatric transplantation | 2024

von Alshami, A. | Bahbah, H. | Al Attas, R. | +2

4

Extreme poverty first : An argument on the equitable distribution of the COVID-19 vaccine in Peru

enthalten in: Developing world bioethics | 2024

von Yabar, C.

CommentIn: Dev World Bioeth. 2023 Sep;23(3):201-202. - PMID 36883580

5

Cell-engineered virus-mimetic nanovesicles for vaccination against enveloped viruses

enthalten in: Journal of extracellular vesicles | 2024

von Han, C. | Kim, S. | Seo, Y. | +7

6

Vaccination and the risk of post-acute sequelae after COVID-19 in the Omicron-predominant period

enthalten in: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases | 2024

von Huh, K. | Kim, Y. | Bae, G. | +6

7

Post COVID-19 condition imposes significant burden in patients with advanced chronic kidney disease : A nested case-control study

enthalten in: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases | 2024

von Bouwmans, P. | Malahe, S. | Messchendorp, A. | +16

8

COVID-19 Vaccination Site Accessibility, United States, December 11, 2020-March 29, 2022

enthalten in: Emerging infectious diseases | 2024

von Yee, R. | Carranza, D. | Kim, C. | +4

9

Interventional Study of Nonpharmaceutical Measures to Prevent COVID-19 Aboard Cruise Ships

enthalten in: Emerging infectious diseases | 2024

von Mouchtouri, V. | Kourentis, L. | Anagnostopoulos, L. | +6

10

SARS-CoV-2 IgG Levels as Predictors of XBB Variant Neutralization, Israel, 2022- and 2023

enthalten in: Emerging infectious diseases | 2024

von Lustig, Y. | Canetti, M. | Indenbaum, V. | +11

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[1164]